SubHero Banner
Text

Actemra® (tocilizumab) – New indication

May 22, 2017 – The FDA announced the approval of Roche’s Actemra (tocilizumab) subcutaneous (SC) injection, for the treatment of adult patients with giant cell arteritis (GCA).

Download PDF